(2005 - 2006)
2022
Serve as a Member of the Advisory Group providing expertise, input and feedback on the BioIndustry Association's 2023 TechBio UK conference content and programming as well as TechBio X initiatives. Investor panel chair and moderator at the inaugural TechBio UK conference (London, UK). https://www.techbio.uk
2022
Serve as Venture Partner for MedTech SuperConnector, an accelerator led by Imperial College London and funded by Research England's £100M Connecting Capability Fund. The accelerator programme is a collaboration of academic institutions with a shared vision to support early career researchers in the development and translation of their early stage medical technology innovations. The partner institutions are: Queen Mary University of London, Bucks New University, The Francis Crick Institute, Imperial College London, Royal College of Art, Royal College of Music, Institute of Cancer Research and Royal Veterinary College. https://medtechsuperconnector.com/
2018
Serve as a mentor for MedTech SuperConnector, an accelerator led by Imperial College London and funded by Research England's £100M Connecting Capability Fund. Mentored an award-winning venture from Imperial College London which went on to receive a €612,000 award from the European Institute of Innovation & Technology and named MedCity 'Company of the Month'. http://medtechsuperconnector.com https://re.ukri.org/funding/our-funds-overview/the-connecting-capability-fund-ccf/
2022
Serve as an Expert-in-Residence (XiR) for Imperial College London's Enterprise Lab, providing advice on investment topics to participating founders leading life sciences and deeptech ventures across emerging bio-platforms, technologies and tools, diagnostics, medical devices and healthtech as well as those at the intersection with sustainability and consumer. Delivered by Imperial's Enterprise Division, Imperial Enterprise Lab supports innovation and entrepreneurial activity throughout the Imperial community by providing access to co-working spaces, entrepreneurial programmes, and expert advice. https://www.imperialenterpriselab.com/ https://www.imperialenterpriselab.com/impact-report-2021/
2020
The RSA has been at the forefront of positive social change for over 260 years, driven by a global Fellowship network with shared values of being open, optimistic, courageous, rigorous and enabling. The RSA Albert Medal is awarded annually to recognise innovations that contribute to a better world for people, place and planet, including Prof Dame Sarah Gilbert in 2021 for her role in the Oxford Vaccine. https://www.thersa.org
2018
2018
Serve as an assessor of innovation funding applications. Innovate UK is part of UK Research & Innovation, the UK funding agency investing in science and research. https://www.ukri.org
2020 - 2021
2020 - 2021
Applying protein engineering in a vaccine technology platform to generate new vaccines with multiple delivery systems against infectious diseases and cancer. https://www.spybiotech.com/
2020 - 2021
2020 - 2021
Oxford Science Enterprises (fka Oxford Sciences Innovation; OSI) transforms world-leading science into world-changing businesses. In partnership with the University of Oxford, since 2015 the company has raised over £850m of capital and established a portfolio of over 100 spinout companies across life sciences and technology, attracting capital from leading co-investors and specialist talent to Oxford's growing science and technology ecosystem. https://oxfordscienceenterprises.com
2020 - 2021
2020 - 2021
Making single-molecule imaging accessible by commercialising the Nanoimager, a super-resolution microscope with applications in academic and industry research. https://oni.bio
2018 - 2020
2018 - 2020
Dedicated to venture-backed portfolio companies across healthcare and technology sectors, collaborating with investors in the UK and globally on syndicated funding rounds, from Series A & beyond. Mercia Asset Management is a publicly-listed specialist asset manager active across debt, venture capital and private equity. http://www.mercia.co.uk/
2017 - 2018
2017 - 2018
Innovation investment and partnering advisory, working with global investors and venture-backed companies.